Health care pharmaceutical companies by one-year price change
How far the share price has moved over the last 52 weeks.
Erasca leads the 61 health care pharmaceutical companies ranked by one-year price change, at +395%, ahead of Spyre Therapeutics (+332%) and Oruka Therapeutics (+255%). Figures as of 19 Nov 2026, 14:43 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Erasca+395%
- Median
- +27.0%
- Combined market value
- CHF 4.22T
- Countries
- 10
Market values as of .
All countries▾
Health Care▾
Pharmaceuticals▾
| # | Company | 1 year ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ErascaERAS · Health Care | +395% | CHF 4.2B | CHF 11.95 | 2.98% up | 395% up | ||
| 2 | Spyre TherapeuticsSYRE · Health Care | +332% | CHF 8.1B | CHF 85.37 | 0.19% down | 332% up | ||
| 3 | Oruka TherapeuticsORKA · Health Care | +255% | CHF 5.5B | CHF 81.41 | 0.87% up | 255% up | ||
| 4 | VeradermicsMANE · Health Care | +231% | CHF 4.5B | CHF 106.18 | 0.84% up | 231% up | ||
| 5 | Definium TherapeuticsDFTX · Health Care | +168% | CHF 3.4B | CHF 24.86 | 1.27% up | 168% up | ||
| 6 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | +129% | CHF 6.3B | CHF 80.05 | 0.10% down | 129% up | ||
| 7 | TG TherapeuticsTGTX · Health Care | +117% | CHF 8.4B | CHF 55.76 | 0.03% up | 117% up | ||
| 8 | Dianthus TherapeuticsDNTH · Health Care | +108% | CHF 4.1B | CHF 72.86 | 2.92% up | 108% up | ||
| 9 | ViatrisVTRS · Health Care | +99.0% | CHF 19.4B | CHF 16.94 | 0.89% down | 99% up | ||
| 10 | Roivant SciencesROIV · Health Care | +91.1% | CHF 23.9B | CHF 32.93 | 0.85% up | 91% up | ||
| 11 | Amneal PharmaceuticalsAMRX · Health Care | +90.0% | CHF 6.4B | CHF 18.24 | 1.10% down | 90% up | ||
| 12 | Praxis Precision MedicinesPRAX · Health Care | +86.0% | CHF 7.6B | CHF 270.36 | 5.08% up | 86% up | ||
| 13 | Edgewise TherapeuticsEWTX · Health Care | +85.9% | CHF 3.8B | CHF 34.35 | 1.50% down | 86% up | ||
| 14 | Royalty PharmaRPRX · Health Care | +78.9% | CHF 33.2B | CHF 57.76 | 0.23% down | 79% up | ||
| 15 | Teva Pharmaceutical IndustriesTEVA · Health Care | +73.9% | CHF 40.2B | CHF 34.43 | 3.23% down | 74% up | ||
| 16 | GenmabGMAB · Health Care | +69.7% | CHF 26.8B | CHF 43.52 | 1.28% up | 70% up | ||
| 17 | AlkermesALKS · Health Care | +66.2% | CHF 6.6B | CHF 39.31 | 0.48% down | 66% up | ||
| 18 | Takeda PharmaceuticalTAK · Health Care | +51.3% | CHF 57.9B | CHF 18.11 | 0.99% up | 51% up | ||
| 19 | Protagonist TherapeuticsPTGX · Health Care | +51.0% | CHF 7B | CHF 107.24 | 0.04% up | 51% up | ||
| 20 | Ligand PharmaceuticalsLGND · Health Care | +50.1% | CHF 5B | CHF 250.34 | 0.59% down | 50% up | ||
| 21 | Merck & CoMRK · Health Care | +45.1% | CHF 281.1B | CHF 114.04 | 1.79% down | 45% up | ||
| 22 | Travere TherapeuticsTVTX · Health Care | +44.7% | CHF 4.1B | CHF 42.54 | 0.45% up | 45% up | ||
| 23 | Belite BioBLTE · Health Care | +43.1% | CHF 5.4B | CHF 132.78 | 0.82% up | 43% up | ||
| 24 | Jazz PharmaceuticalsJAZZ · Health Care | +41.0% | CHF 13.3B | CHF 206.66 | 1.06% down | 41% up | ||
| 25 | Johnson & JohnsonJNJ · Health Care | +34.3% | CHF 543.3B | CHF 225.67 | 1.84% down | 34% up | ||
| 26 | Mirum PharmaceuticalsMIRM · Health Care | +33.7% | CHF 5.1B | CHF 78.07 | 0.13% up | 34% up | ||
| 27 | Eli LillyLLY · Health Care | +32.5% | CHF 1.03T | CHF 1,152.14 | 1.13% down | 33% up | ||
| 28 | Bristol-Myers SquibbBMY · Health Care | +29.6% | CHF 100.9B | CHF 49.38 | 1.65% down | 30% up | ||
| 29 | Ascendis PharmaASND · Health Care | +29.0% | CHF 14.9B | CHF 227.62 | 0.12% down | 29% up | ||
| 30 | Regeneron PharmaceuticalsREGN · Health Care | +28.3% | CHF 81.5B | CHF 788.11 | 1.13% down | 28% up | ||
| 31 | Vertex PharmaceuticalsVRTX · Health Care | +27.0% | CHF 114.1B | CHF 449.85 | 0.53% down | 27% up | ||
| 32 | Elanco Animal HealthELAN · Health Care | +25.7% | CHF 11.3B | CHF 22.69 | 0.82% up | 26% up | ||
| 33 | NovartisNVS · Health Care | +24.8% | CHF 241.5B | CHF 127.89 | 2.29% down | 25% up | ||
| 34 | AbbVieABBV · Health Care | +24.7% | CHF 420.7B | CHF 238.00 | 1.27% down | 25% up | ||
| 35 | United TherapeuticsUTHR · Health Care | +21.6% | CHF 20.5B | CHF 482.46 | 0.87% down | 22% up | ||
| 36 | BridgeBio PharmaBBIO · Health Care | +20.7% | CHF 13B | CHF 66.86 | 1.67% up | 21% up | ||
| 37 | Rhythm PharmaceuticalsRYTM · Health Care | +18.3% | CHF 6.9B | CHF 99.76 | 0.59% down | 18% up | ||
| 38 | BioMarin PharmaceuticalBMRN · Health Care | +17.1% | CHF 10.1B | CHF 52.31 | 1.00% up | 17% up | ||
| 39 | BeOne MedicinesONC · Health Care | +15.5% | CHF 38.8B | CHF 339.98 | 0.08% down | 16% up | ||
| 40 | PfizerPFE · Health Care | +15.0% | CHF 133.3B | CHF 23.39 | 1.12% down | 15% up | ||
| 41 | Arrowhead PharmaceuticalsARWR · Health Care | +13.2% | CHF 5.1B | CHF 36.27 | 0.20% down | 13% up | ||
| 42 | Dr. Reddy's LaboratoriesRDY · Health Care | +7.77% | CHF 10.5B | CHF 12.58 | 0.40% down | 8% up | ||
| 43 | GSKGSK · Health Care | +5.36% | CHF 81.1B | CHF 40.47 | 1.17% down | 5% up | ||
| 44 | AstraZenecaAZN · Health Care | +0.79% | CHF 230.5B | CHF 148.61 | 1.39% down | 1% up | ||
| 45 | GrifolsGRFS · Health Care | +0.47% | CHF 4.8B | CHF 7.03 | 1.53% down | 0% up | ||
| 46 | SanofiSNY · Health Care | -3.62% | CHF 93.3B | CHF 38.86 | 2.16% down | 4% down | ||
| 47 | Axsome TherapeuticsAXSM · Health Care | -6.50% | CHF 6B | CHF 113.67 | 0.63% up | 6% down | ||
| 48 | Corcept TherapeuticsCORT · Health Care | -9.67% | CHF 6.3B | CHF 57.13 | 0.04% down | 10% down | ||
| 49 | Abbott LaboratoriesABT · Health Care | -15.7% | CHF 153.5B | CHF 88.63 | 0.62% up | 16% down | ||
| 50 | Novo NordiskNVO · Health Care | -17.2% | CHF 146.2B | CHF 33.17 | 0.25% down | 17% down | ||
| 51 | CytokineticsCYTK · Health Care | -19.2% | CHF 6.1B | CHF 43.58 | 0.74% up | 19% down | ||
| 52 | Cogent BiosciencesCOGT · Health Care | -19.9% | CHF 4.1B | CHF 23.60 | 0.68% up | 20% down | ||
| 53 | PTC TherapeuticsPTCT · Health Care | -21.2% | CHF 4.2B | CHF 50.41 | 0.71% down | 21% down | ||
| 54 | ZoetisZTS · Health Care | -26.2% | CHF 28.5B | CHF 70.17 | 2.72% down | 26% down | ||
| 55 | Madrigal PharmaceuticalsMDGL · Health Care | -26.6% | CHF 7.9B | CHF 338.48 | 0.86% up | 27% down | ||
| 56 | ABIVAXABVX · Health Care | -31.8% | CHF 6.2B | CHF 70.62 | 0.07% down | 32% down | ||
| 57 | Summit TherapeuticsSMMT · Health Care | -36.2% | CHF 7B | CHF 8.78 | 0.86% down | 36% down | ||
| 58 | InsmedINSM · Health Care | -40.0% | CHF 22.4B | CHF 102.03 | 1.02% up | 40% down | ||
| 59 | Legend BiotechLEGN · Health Care | -41.0% | CHF 2.6B | CHF 13.57 | 0.92% down | 41% down | ||
| 60 | Ionis PharmaceuticalsIONS · Health Care | -62.5% | CHF 3.8B | CHF 22.98 | 0.47% down | 63% down | ||
| 61 | Alnylam PharmaceuticalsALNY · Health Care | -66.5% | CHF 16.9B | CHF 126.18 | 0.19% up | 66% down |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 0.8430 CHF).
Questions and answers
Which health care pharmaceutical companies rank first by one-year price change?
Erasca (+395%), Spyre Therapeutics (+332%) and Oruka Therapeutics (+255%) are the top three of the 61 health care pharmaceutical companies ranked by one-year price change as of 19 Nov 2026, 14:43 UTC.
How many health care pharmaceutical companies are in this ranking?
61 are ranked by one-year price change.
What are these health care pharmaceutical companies worth together?
The 61 health care pharmaceutical companies ranked by one-year price change have a combined market value of CHF 4.22T as of 19 Nov 2026, 14:43 UTC.
What does ranking by one-year price change measure?
How far the share price has moved over the last 52 weeks.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care pharmaceutical companies by one-year price change”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?sector=health-care&by=year-change
Underlying data: Yahoo Finance; SEC EDGAR.